TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Monopar Therapeutics Inc.
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025

Monopar Therapeutics presented new data at AASLD showing that ALXN1840 (tiomolybdate choline) rapidly improved copper balance in Wilson disease patients through increased fecal copper excretion.

Insights
JPM   neutral

CEO's comments highlighted potential broader market risks, but not directly negative about the company itself


MNPR   positive

Presented promising clinical study results demonstrating potential effectiveness of their drug ALXN1840 in treating Wilson disease, indicating positive research progress